The U.S. Food and Drug Administration (FDA) has taken a crucial step to protect public health: it has banned the use of Red Dye No. 3 in all food products. This synthetic dye, known for giving a ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

FY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, plus more biotech ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

Is the shortage of ADHD drugs, especially Adderall, forcing children to constantly switch medications?In a new study, researchers compared stimulant rates for k ...

ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...

Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to ...

Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder (ADHD) to other ...

Having ADHD is associated with a shorter life expectancy and a greater risk of mental health issues, according to a new study ...

The efforts made by the FDA to ban synthetic dye has sparked a new awareness of artificial chemical compounds that do more than just add color.